94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Wei Yang1†
Fusheng Ge1†
Shuaibing Lu1†
Zhiming Shan2Liangqun Peng1Junhui Chai1Hongxing Liu1Baodong Li1Zhandong Zhang1Jinxi Huang1
Yawei Hua1*Yonglei Zhang1*- 1Department of General Surgery, The Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
- 2Clinical Laboratory, The Children's Hospital of Henan Province, Zhengzhou Children's Hospital, The Affiliated Children Hospital of Zhengzhou University, Zhengzhou, China
A Corrigendum on
LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
by Yang, W., Ge, F., Lu, S., Shan, Z., Peng, L., Chai, J., Liu, H., Li, B., Zhang, Z., Huang, J., Hua, Y., and Zhang, Y. (2021). Front. Med. 8:795427. doi: 10.3389/fmed.2021.795427
Shuaibing Lu was not listed as a co-first author in the published article. The corrected author list appears below.
Wei Yang1†, Fusheng Ge1†, Shuaibing Lu1†, Zhiming Shan2, Liangqun Peng1, Junhui Chai1, Hongxing Liu1, Baodong Li1, Zhandong Zhang1, Jinxi Huang1, Yawei Hua1* and Yonglei Zhang1*
In the published article, there was an error in affiliation 1. Instead of “Department of General Surgery, Henan Cancer Hospital, Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China,” it should be “Department of General Surgery, The Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.”
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: lncRNA MSC-AS1, prognosis, gastric cancer, bioinformatics, biomarker
Citation: Yang W, Ge F, Lu S, Shan Z, Peng L, Chai J, Liu H, Li B, Zhang Z, Huang J, Hua Y and Zhang Y (2022) Corrigendum: LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis. Front. Med. 9:862010. doi: 10.3389/fmed.2022.862010
Received: 25 January 2022; Accepted: 27 January 2022;
Published: 17 February 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Yang, Ge, Lu, Shan, Peng, Chai, Liu, Li, Zhang, Huang, Hua and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yawei Hua, aHVheWF3ZWkxOTY1QDE2My5jb20=; Yonglei Zhang, eGlhb3ltMTI4OTEwQDE2My5jb20=
†These authors have contributed equally to this work